gonanes - CISMeF

Preferred Label : gonanes;

MeSH definition : Steroids containing the fundamental tetracyclic unit with no methyl groups at C-10 and C-13 and with no side chain at C-17. The concept includes both saturated and unsaturated derivatives.;

MeSH annotation : includes gonenes, gonadienes, gonatrienes;

Wikipedia link : https://en.wikipedia.org/wiki/Gonanes;

Is substance : O;

Détails

Origin ID

D006067;

UMLS CUI

C0018068;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Prednisolone [NCIt concept]
Record concept(s)
- gonanes [MeSH concept]
Related MeSH Supplementary Concept(s)
- 12,15-bisthia-1,3,5(10),6,8,13(14)-gonahexaen-17-one [MeSH Supplementary Concept]
- 13-ethyl-15-hydroxygon-4-ene-3,17-dione [MeSH Supplementary Concept]
- 13-ethyl-17-hydroxy-gon-4-en-3-one [MeSH Supplementary Concept]
- 13-ethyl-3-methoxy-8,14-secogona-1,3,5(10),9(11)-tetraene-14,17-dione [MeSH Supplementary Concept]
- 13-ethyl-gon-4-ene-3,17-dione [MeSH Supplementary Concept]
- 15,16-dihydro-1,11-methanocyclopenta(a)phenanthren-17-one [MeSH Supplementary Concept]
- 15,16-dihydro-11-methylcyclopenta(a)phenanthren-17-one [MeSH Supplementary Concept]
- 15,16-dihydro-12-methylcyclopenta(a)phenanthren-17-one [MeSH Supplementary Concept]
- 15,16-dihydro-6-methylcyclopenta(a)phenanthren-17-one [MeSH Supplementary Concept]
- 15,16-dihydrocyclopenta(a)phenanthren-17-one [MeSH Supplementary Concept]
- 15-methyl-8-aza-16-oxagona-1,3,5(10),13-tetraen-17-one [MeSH Supplementary Concept]
- 17beta-hydroxy-16alpha-iodoPX866 [MeSH Supplementary Concept]
- 3,4,15,16-tetrahydro-3,4-dihydroxy-11-methyl-17H-cyclopenta(a)phenanthren-17-one [MeSH Supplementary Concept]
- PX-866 [MeSH Supplementary Concept]
- RU 50331 [MeSH Supplementary Concept]
- ZK 115716 [MeSH Supplementary Concept]
- cyclopentaphenanthrene [MeSH Supplementary Concept]
- homo-12,15-bisthia-1,3,5(10),6,8,13-gonahexaen-17-one [MeSH Supplementary Concept]
- onapristone [MeSH Supplementary Concept]
- tetrazanbigen [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients